About Chenguang Biotechnology Group
Chenguang Biotechnology Group is a publicly listed company based in China founded in 2000. Manufacturer of natural plant extract-based products for food, cosmetics, and other industries. Chenguang Biotechnology Group has raised $7.17 million across 1 funding round from investors including Fortune Capital and Junrun Capital. The company has 1,870 employees. Its Indian entity Chenguang Bio-Tech (India) Private Limited reported revenue of ₹124 Cr. Chenguang Biotechnology Group offers products and services including Natural Pigments and Spice Extracts. Its focus areas include Food and Agriculture, Food Processing, Food Ingredients and Multi-Category.
Company details
Established in 2000 in Hebei, China, operations focus on the biotechnology sector. Natural plant extract-based products are researched, developed, and produced from agricultural materials. Applications span food, cosmetics, baking, beverages, health supplements, and animal feed. Facilities include centers for research and development, testing, and pilot production. Offerings cover natural pigments, spice extracts, essential oils, nutritional and medicinal extracts, natural sweeteners, specialty oils, health supplements, and animal health items.
- Indian entity revenue₹124 Cr
FY 2021 · +32% YoY
- Indian entity net profit₹7.86 Cr
FY 2021 · 6% margin
- Indian entity EBITDA-₹4.06 Cr
FY 2021 · -3% margin
- Total Equity Funding$7.17M (USD)
in 1 rounds
- Latest Funding Round$7.17M (USD), Series A
Sep 2009
- InvestorsFortune Capital
& 1 more
- Employee Count1,870
Associated legal entities of Chenguang Biotechnology Group
Chenguang Biotechnology Group operates through Chenguang Bio-Tech (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Chenguang Bio-Tech (India) Private Limited CIN U01403AP2010PTC070338 | Active | 07 Sep 2010 | Khammam, Andhra Pradesh | ₹124 Cr | 60 | 3 | View details |
Products & Services of Chenguang Biotechnology Group
Chenguang Biotechnology Group offers a comprehensive portfolio of products and services, including Natural Pigments and Spice Extracts.
Natural pigments are extracted and produced from plant sources for use in food and cosmetics industries
Spice extracts and essential oils are manufactured for applications in food, beverages, and other sectors
Funding Insights of Chenguang Biotechnology Group
Chenguang Biotechnology Group has successfully raised a total of $7.17M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.17 million completed in September 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.17M
- Total Rounds 1
- Last Round Series A — $7.17M
- First Round $7.17M
(Sep 2009)
- Investors Count 2
All 1 funding rounds of Chenguang Biotechnology Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2009 | $7.17M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Chenguang Biotechnology Group
Chenguang Biotechnology Group has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Fortune Capital and Junrun Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| fortunevc.com | ||||
| jrcapital.com.cn |
Investor details for Chenguang Biotechnology Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Chenguang Bio-Tech (India) Private Limited (Chenguang Biotechnology Group)
Chenguang Bio-Tech (India) Private Limited is the primary company behind Chenguang Biotechnology Group. The board of Chenguang Bio-Tech (India) Private Limited currently have 3 directors; the longest-serving is Lu Qingguo, appointed in 2010. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lu Qingguo DIN 03115768 | Director | 07 Sep 2010 | 16 yrs 2 mo | Chenguang Bio-Tech (India) Private Limited |
| Qi Lijun DIN 03347216 | Director | 03 Jan 2011 | 15 yrs 10 mo | Chenguang Bio-Tech (India) Private Limited |
| Ravindra Potu DIN 11270446 | Additional Director | 18 Sep 2025 | 1 yr 1 mo | Chenguang Bio-Tech (India) Private Limited |
IPO & Listings of Chenguang Biotechnology Group
Chenguang Biotechnology Group is a publicly listed company on the SZSE with ticker symbol 300138 in China, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2010
- Listed onSZSE: 300138
- Listed entityChenguang Biotech Group Co., Ltd. Class A
- Exchange sectorConsumer non-durables
- ISINCNE100000WC5
- Share price11.26 CNY (-3.51% on the day) · 2026-10-14
- Market capitalisation5,637,778,139.00 CNY
- Price to earnings16.4
- EPS (diluted, trailing year)0.69 CNY
- Dividend yield2.57%
- Volume (last session)7,875,288
Financials of Chenguang Biotechnology Group
Figures of Chenguang Bio-Tech (India) Private Limited, the primary company behind Chenguang Biotechnology Group, for FY 2021. Revenue was ₹124 Cr (+32% year on year). Net profit was ₹7.86 Cr (6% margin). EBITDA was -₹4.06 Cr (-3% margin). Revenue has grown at a compounded annual rate of -33% over three years and -10% over five years.
- ₹124 CrRevenue · FY 2021 · +32% YoY
- ₹7.86 CrNet profit · 6% margin
- -₹4.06 CrEBITDA · -3% margin
- ₹9.00 CrPaid-up capital
- 60Employees (provident fund records)
- -33%Revenue CAGR, 3 years
- -10%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.55B CNY | 368.9M CNY | 594.5M CNY |
| 2024 | 6.98B CNY | 94.0M CNY | 287.4M CNY |
| 2023 | 6.87B CNY | 479.7M CNY | 633.4M CNY |
| 2022 | 6.29B CNY | 434.0M CNY | 593.4M CNY |
| 2021 | 4.87B CNY | 351.5M CNY | 516.6M CNY |
Balance sheet, profit and loss, cash flow and ratios of Chenguang Bio-Tech (India) Private Limited are on its company page.
Detailed financial statements for Chenguang Biotechnology Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Chenguang Biotechnology Group
3 dated milestones of Chenguang Biotechnology Group across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Chenguang Biotechnology Group is founded.
- Funding First funding round of $7.2M.
- IPO Lists on the stock exchange (IPO).
Web traffic of Chenguang Biotechnology Group
The website of Chenguang Biotechnology Group (cn-cg.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 58.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chenguang Biotechnology Group
Complete news archive for Chenguang Biotechnology Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chenguang Biotechnology Group
Chenguang Biotechnology Group was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Chenguang Biotechnology Group is headquartered in China. It is registered at Hebei, China.
Chenguang Biotechnology Group is a funded company, having raised a total of $7.17M across 1 funding round to date. The company's 1st funding round was a Series A of $7.17M, raised on Sep 2009.
Chenguang Biotechnology Group has 1,870 employees.
The primary company behind Chenguang Biotechnology Group, Chenguang Bio-Tech (India) Private Limited, reported revenue of ₹124 Cr for FY 2021, up 32% year on year.
Established in 2000 in Hebei, China, operations focus on the biotechnology sector. Natural plant extract-based products are researched, developed, and produced from agricultural materials. Applications span food, cosmetics, baking, beverages, health supplements, and animal feed. Facilities include centers for research and development, testing, and pilot production. Offerings cover natural pigments, spice extracts, essential oils, nutritional and medicinal extracts, natural sweeteners, specialty oils, health supplements, and animal health items.
Chenguang Biotechnology Group offers Natural Pigments and Spice Extracts.
Yes, Chenguang Biotechnology Group is publicly traded on SZSE under the ticker symbol 300138.
Chenguang Biotechnology Group has 2 investors. Key investors include Fortune Capital, and Junrun Capital.
Chenguang Biotechnology Group operates through Chenguang Bio-Tech (India) Private Limited.
The legal entities of Chenguang Biotechnology Group currently have 3 directors, including Qi Lijun, Lu Qingguo, Ravindra Potu.